Eye Disease

Researchers at UCL have identified a protein called LRG1 that initiates the earliest damage in diabetic retinopathy, a major cause of vision loss in adults with diabetes. In mouse studies, blocking LRG1 prevented retinal harm and preserved eye function. The findings suggest potential for new preventive treatments targeting this protein.